Albendazole; ATC-Code: P02CA03
Albendazol; ATC-Code: P02CA03
Germany · Dresden · how to bid here →
Your path to submission
- Deadline: 5 September at 21:59 — 719 days left.
- The submission point is stated in the notice (link on the right).
- Collect your evidence — use the eligibility analysis above: it lists the requirements and, for known certificates, how to get them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 2 months (1000 awards, most recently September 2026) — the next award is due around November 2026 by that rhythm. The last award went to G.L. Pharma Deutschland GmbH.n = 1,000
- 66% of this buyer's awards went to companies that had already won here before (1,772 awards since 2018, spread over 606 companies). 34% went to new names.n = 1,772 awards since 2018
- The award came in at a median 70% of the estimated value (7 awards with both estimate and value) — pricing at the estimate is usually too high here. Sector: 87%.n = 7
- The median procedure drew 2 bids (1,745 procedures with a bid count); 43% ended with a single bidder. Sector: median 2 bids.n = 1,745
- < 1% of the bids received came from other countries (140 procedures with a bid mix) — all bidders, not just the winners. Sector: 5%.n = 140
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 17/09/2026.
Foreign bidders
In Germany · Medical equipment & pharma, 257 contracts went to foreign companies over the last 3 years (of 21,997 recorded awards) — mostly from Austria, Netherlands, France.
Typical field: median 17 (from 1,475 awards).
What the buyer is looking for
The summary in English is being prepared. The official description below is in the original language (DE).
Show original description (DE)
Albendazol; ATC-Code: P02CA03 Apixaban; ATC-Code: B01AF02 Aripiprazol; Depotformulierungen; ATC-Code: N05AX12 Colistimethat; ATC-Code: J01XB01 Dapagliflozin; ATC-Code: A10BK01 Dapagliflozin und Metformin; ATC-Code: A10BD15 Dornase alfa; ATC-Code: R05CB13 Estriol; ATC-Code: G03CA04 Incobotulinumtoxin; ATC-Code: M03AX21 (ADV), M03AX01 (WHO) Indacaterol und Glycopyrronium; ATC-Code: R03AL04 Infliximab; intravenöse Applikation; ATC-Code: L04AB02 Infliximab; subkutane Applikation; ATC-Code: L04AB02 Macrogol; ATC-Code: A06AD15 Multienzyme; ohne 20.000 und 25.000 Einheiten; ATC-Code: A09AA02 Nabilon; ATC-Code: A04AD11 Onabotulinumtoxin; ATC-Code: M03AX21 (ADV), M03AX01 (WHO) Oseltamivir; ATC-Code: J05AH02 Piperacillin und Tazobactam; ATC-Code: J01CR05 Pivmecillinam; ATC-Code: J01CA08 Prednicarbat; ATC-Code: D07AC18 Tobramycin; Hartkapseln mit Pulver zur Inhalation; ATC-Code: J01GB01
Eligibility analysis from the tender documents
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Abacus Medicine A/S · Kopenhagen | 59 | 2015–2026 |
| EurimPharm Arzneimittel GmbH · Saaldorf-Surheim | 50 | 2016–2026 |
| CC Pharma GmbH · Densborn | 42 | 2012–2023 |
| kohlpharma GmbH · Merzig | 40 | 2014–2023 |
| Aliud Pharma GmbH · Laichingen | 36 | 2011–2023 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.